CITIUS ONCOLOGY, INC. Earnings Per Share Diluted

Quick Answer

CITIUS ONCOLOGY, INC. reported Earnings Per Share Diluted of $0.34 (loss) per share for the year ending 2025.

  • CITIUS ONCOLOGY, INC. showed a decrease of -9.7% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from CITIUS ONCOLOGY, INC.'s annual report (Form 10-K), filed with the SEC on December 23, 2025.
  • XBRL data for this metric is available from 2022 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2022 to 2025), CITIUS ONCOLOGY, INC.'s Earnings Per Share Diluted has declined by 383.3%.
  • Historical annual values: Fiscal year 2025: $0.34 (loss) per share | Fiscal year 2024: $0.31 (loss) per share | Fiscal year 2023: $0.27 per share | Fiscal year 2023: $0.19 (loss) per share | Fiscal year 2022: $0.12 per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: